glutathione therapy for parkinson' Revamping Parkinson's disease using PLGA-based drug delivery systems Frontiers | Understanding Parkinson's disease:

Modern immunosuppressive medications are highly effective at curbing bouts of inflammation, but have surprisingly limited effectiveness on disease progression

& Girardi, A

SAMe is the most important methyl donor in the body and participates in the methylation modification of DNA, RNA, proteins (including histones), phospholipids, neurotransmitters, etc

(1970) Genetic activity of some cyclohexane derivatives

Gut Microbes (2021) 13(1):1949096

Moreover, dihydropyridine compounds with good central nervous system (CNS) penetration, such as nimodipine showed promising mood stabilizing effects in humans with affective disorders, suggesting that LTCC antagonists represent an additional option in the pharmacotherapy of psychiatric diseases, and especially patients carrying the CACNA1C risk SNP could benefit from this alternative treatment strategy 13,43,52